- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 35.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 37.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 40.97M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $54.53M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $460K |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $1.49M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.61M |
| Capex | Q1 2026 · Mar 31, 2026 | $5.22M |
| Capex | Q1 2026 · Mar 31, 2025 | $12.94M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$19.38M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $9.19M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.31B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $30.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.45B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $705.59M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $327.52M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $183.67M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $847.32M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $779.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.59B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $462.67M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.49B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $21.40 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $21.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.31 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $29.99M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $30.97M |
| Net Income | Q1 2026 · Mar 31, 2026 | $800.83M |
| Net Income | Q1 2026 · Mar 31, 2025 | $12.42M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $6.89M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $7.15M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $36.87M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $32.83M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $131.41M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $119.63M |
| Revenue | Q1 2026 · Mar 31, 2026 | $168.28M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $152.46M |